Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for David Morgan

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGHEME4412

    08/18/2016

    A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma


    Print this page for your doctor